相关实验视频
Updated: Jan 15, 2026

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
6.0K
E3 无处不在的酶 Trip12 半选择性地减弱了 Wnt 信号传递
Jessica Ensing1, Amber D Ide1, Carla Gilliland1
1Department of Cell Biology, Van Andel Institute, Grand Rapids, MI 49503, USA.
iScience
|October 16, 2025
概括
这种E3泛基因酶Trip12针对Frizzled 9b (Fzd9b),促进其降解并抑制Wnt9a/Fzd9b信号传输. 这种受体特异性调节会影响造血干细胞的增殖.
科学领域:
- 分子生物学分子生物学
- 发展生物学 发展生物学
- 细胞信号传递 细胞信号传递
背景情况:
- Wnt信号传递对于造血干细胞 (HSC) 的发育和维护至关重要.
- 失调的Wnt信号,特别是过度激活,与瘤发生有关.
- 了解特定Frizzled (Fzd) 受体的负调节对于控制Wnt通路活动至关重要.
研究的目的:
- 阐明控制Wnt9a/Fzd9b信号激活和终止的机制.
- 为了确定Fzd9b膜表达和稳定性的调节者.
- 为了研究Trip12在调节HSC中的Wnt9a/Fzd9b信号传递中的作用.
主要方法:
- 利用生物化学分析来确定Fzd9b上的Trip12的目标部位.
- 研究了Trip12对Fzd9b膜表达和溶酶体降解的影响.
- 评估了Trip12介导的Fzd9b调控对斑马鱼模型中HSC增殖的影响.
主要成果:
- 鉴定了E3泛基因酶Trip12作为Fzd9b.b的调节者.
- 证明Trip12针对Fzd9b在K437的第三个细胞内循环,促进其溶酶体降解.
- 显示Trip12破坏Fzd9b膜表达的稳定,抑制Wnt9a/Fzd9b信号传递,影响斑马鱼的HSC增殖.
结论:
- Trip12作为Fzd9b的负调节剂,控制其表面表达和稳定性.
- 这种特定于受体的机制微调Wnt9a/Fzd9b的信号强度.
- 研究结果为涉及HSC失调的疾病提供了针对性Wnt通路治疗的见解.
相关概念视频
Canonical Wnt Signaling Pathway
10.4K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
Non-Canonical Wnt Signaling Pathways
8.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.3K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K

